Sandeep Dave, MD, MS
Research Interests
Leukemias and lymphomas are malignancies that arise from immune cells. The majority of these malignancies arise from B cells, a type of immune cell. Leukemias and lymphomas derived from B cells affect over 100,000 Americans every year. The majority of those patients will succumb to their disease. Dr. Dave's research is focused on the application of high-throughput technologies including microarrays and massively parallel sequencing to improve the diagnosis and treatment of leukemias and lymphomas.
Active efforts in the laboratory and clinic include:
- Integrating genomic technologies with clinical trials to define molecular subgroups of patients who are most likely to respond to therapy.
- Exploring the role of microRNA in the differentiation of immune cells and their role in leukemias and lymphomas.
- Application of high throughput sequencing to identify means of gene regulation in normal and malignant cells.
- Exploiting high throughput genomic and proteomic technologies to develop new prognostic and diagnostic markers in leukemias and lymphomas.
Contact Information
Sandeep Dave
Phone: 919-681-1922
FCIEMAS 2177C
Box DUMC 3382
sandeep.dave@duke.edu